RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bausch Health Companies Stock

Bausch Health Companies Equity 2025

Bausch Health Companies Equity

-1.28 B USD

Ticker

BHC.TO

ISIN

CA0717341071

WKN

A2JQ1X

In 2025, Bausch Health Companies's equity was -1.28 B USD, a 25.15% increase from the -1.02 B USD equity in the previous year.

Bausch Health Companies Aktienanalyse

What does Bausch Health Companies do?

Bausch Health Companies Inc is a Canadian pharmaceutical company that was founded in 2013. However, the company's history dates back to 1853 when John Jacob Bausch and Henry Lomb founded their own company in the USA. This company specialized in optical products, particularly eyeglass frames and lenses. Over the years, the company expanded its product range and also became involved in the production of contact lenses in the 1960s. In the 1970s, the company began to focus on the medical devices sector and expanded in this area through various acquisitions. In the 1990s, the company also established itself in the pharmaceutical sector by building various channels for the distribution of medications. In 2013, the company was renamed and restructured due to financial problems, and in the future, it operated under the name Bausch Health Companies Inc. The company's business model is based on the development, manufacture, and marketing of products in the medical and ophthalmology fields. The company works closely with various institutions such as doctors, pharmacies, and hospitals to ensure that its products are used optimally. The company operates in various areas, including: - Ophthalmology: Bausch Health Companies offers various products in the field of ophthalmology, including contact lenses, eye drops, and other medications that can be used to treat eye diseases such as cataracts or glaucoma. - Dermatology: The company also develops and markets products in the field of dermatology, including medications for the treatment of acne, rosacea, and psoriasis. - Gastroenterology: Bausch Health Companies also produces medications for the treatment of gastrointestinal diseases, such as medications for ulcers or inflammatory bowel diseases. - Neurology: The company manufactures medications for the treatment of neurological disorders, such as epilepsy or migraines. - Urology: Bausch Health Companies also offers products in the field of urology, including medications for the treatment of urinary tract infections or bladder problems. One of the most well-known products of Bausch Health Companies is the brand Bausch + Lomb, which operates in the field of ophthalmology and offers various contact lenses and eye drops. Another well-known product is Jublia, a medication for nail fungus. Overall, Bausch Health Companies is a leading company in the field of medicine and ophthalmology with a long history. With its diverse range of medications and products, it offers effective and reliable solutions for the treatment of various conditions to patients worldwide. Bausch Health Companies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Bausch Health Companies's Equity

Bausch Health Companies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bausch Health Companies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bausch Health Companies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bausch Health Companies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bausch Health Companies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bausch Health Companies stock

What is the equity of Bausch Health Companies this year?

Bausch Health Companies has equity of -1.28 B USD this year.

What was the equity of Bausch Health Companies compared to the previous year?

The equity of Bausch Health Companies has increased/decreased by 25.15% increased compared to the previous year.

What impact does a high equity have on investors of Bausch Health Companies?

A high equity is advantageous for investors of Bausch Health Companies as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bausch Health Companies?

A low equity can be a risk for investors of Bausch Health Companies, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bausch Health Companies affect the company?

An increase in equity of Bausch Health Companies can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bausch Health Companies affect the company?

A reduction in equity of Bausch Health Companies can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bausch Health Companies?

Some factors that can affect the equity of Bausch Health Companies include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bausch Health Companies so important for investors?

The equity of Bausch Health Companies is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bausch Health Companies take to change the equity?

To change equity, Bausch Health Companies can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bausch Health Companies pay?

Over the past 12 months, Bausch Health Companies paid a dividend of 1.28 USD . This corresponds to a dividend yield of about 20.04 %. For the coming 12 months, Bausch Health Companies is expected to pay a dividend of 4.83 USD.

What is the dividend yield of Bausch Health Companies?

The current dividend yield of Bausch Health Companies is 20.04 %.

When does Bausch Health Companies pay dividends?

Bausch Health Companies pays a quarterly dividend. This is distributed in the months of April, June, September, December.

How secure is the dividend of Bausch Health Companies?

Bausch Health Companies paid dividends every year for the past 6 years.

What is the dividend of Bausch Health Companies?

For the upcoming 12 months, dividends amounting to 4.83 USD are expected. This corresponds to a dividend yield of 75.61 %.

In which sector is Bausch Health Companies located?

Bausch Health Companies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bausch Health Companies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bausch Health Companies from 12/22/2010 amounting to 1 USD, you needed to have the stock in your portfolio before the ex-date on 11/10/2010.

When did Bausch Health Companies pay the last dividend?

The last dividend was paid out on 12/22/2010.

What was the dividend of Bausch Health Companies in the year 2024?

In the year 2024, Bausch Health Companies distributed 0 USD as dividends.

In which currency does Bausch Health Companies pay out the dividend?

The dividends of Bausch Health Companies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bausch Health Companies stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bausch Health Companies

Our stock analysis for Bausch Health Companies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bausch Health Companies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.